Krish Patel, MD

Krish Patel, MD, is a hematologist and medical oncologist at SCRI Oncology Partners and director of lymphoma research at the Sarah Cannon Research Institute in Nashville, Tennessee.

Articles by Krish Patel, MD

Latest Advances in Lymphoma and CLL Treatment: Insights From Dr Krish Patel

ByKrish Patel, MD

December 15th 2025

Join Dr Krish Patel and discover groundbreaking updates in lymphoma and CLL treatments, including innovative therapies and promising trial results.

Integrating Technology With Expert Oversight Can Simplify Clinical Trial Enrollment

ByEric Lander, MD,Andrew McKenzie, PhD,Krish Patel, MD

September 30th 2025

Central Screening revolutionizes clinical trial enrollment by integrating technology and expertise, streamlining patient matching for targeted cancer therapies.

Expert Highlights Areas of Research in MCL

ByKrish Patel, MD

February 11th 2019

Krish Patel, MD, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma.

Real-World Data for Ibrutinib in Relapsed/Refractory MCL

ByKrish Patel, MD

January 15th 2019

Kris Patel, MD, discusses the real-world data for treatment with ibrutinib in patients with relapsed/refractory mantle cell lymphoma as compared to clinical trials.